Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study

ClinicalTrials.gov ID: NCT07522606

Public ClinicalTrials.gov record NCT07522606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 28, 2026, 2:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Program is designed to provide continued access BIA 28-6156, free and compassionately for an eligible patient previously enrolled in the BIA 28-6156-201 (ACTIVATE) clinical study and that had completed the study.

Study identification

NCT ID
NCT07522606
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Bial R&D Investments, S.A.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 9, 2026

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
University of Colorado Aurora Colorado 80045 —
Parkinson's Center and Movement Disorders of Boca Raton Boca Raton Florida 33486 —
University of Miami, Dept. of Neurology Miami Florida 33136 —
Northwestern University Chicago Illinois 60611 —
University of Kansas Medical Center Kansas City Kansas 66103 —
University of Kentucky Lexington Kentucky 40536 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Park Nicollet Struther's Parkinson's Center (Struthers Parkinsons Center at HealthPartners) Saint Paul Minnesota 55427 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
MUSC Charleston South Carolina 29425 —
Vanderbilt Medical Center Nashville Tennessee 37232 —
Intermountain Healthcare Salt Lake City Utah 84107 —
University of Washington Seattle Washington 98195 —
Inland Northwest Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07522606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2026 · Synced Sep 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07522606 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →